18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a single centre, single arm feasibility study of 18FCH PET-MR imaging for staging
patients with high risk prostate cancer.
Study Hypothesis:
FCH-PET/MR will enable more accurate staging of patients with high risk prostate cancer as
compared to conventional imaging.
Phase:
N/A
Details
Lead Sponsor:
University Health Network, Toronto
Collaborators:
Prostate Cancer Canada Prostate Cancer Canada Network